| Serial Number | 88141747 |
| Word Mark | CHOLESTOSOME |
| Filing Date | Wednesday, October 3, 2018 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, December 12, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 10, 2019 |
| Goods and Services | Pharmaceutical preparations for Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), and ankylosing spondylitis; vaccines and vaccinations to prevent or treat infectious diseases and cancer; drug delivery agents in the form of capsules made of lipids, containing and facilitating the delivery of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), ankylosing spondylitis; vaccines and vaccinations to prevent or treat infectious diseases and cancer; drug delivery agents in the form of capsules made of cholesteryl ester, containing and facilitating the delivery of pharmaceuticals for use in the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non- alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), and ankylosing spondylitis; and vaccines and vaccinations to prevent or treat infectious diseases and cancer |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 12, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Therasyn Sensors, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Buffalo, NY 142263246 |
| Party Name | Therasyn Sensors, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Buffalo, NY 142263246 |
| Event Date | Event Description |
| Monday, December 12, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, December 12, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, April 26, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, April 25, 2022 | SOU EXTENSION 5 GRANTED |
| Wednesday, April 20, 2022 | SOU EXTENSION 5 FILED |
| Monday, April 25, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, April 20, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 18, 2022 | ASSIGNED TO EXAMINER |
| Saturday, November 6, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 4, 2021 | SOU EXTENSION 4 GRANTED |
| Thursday, November 4, 2021 | SOU EXTENSION 4 FILED |
| Thursday, November 4, 2021 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, April 28, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, April 26, 2021 | SOU EXTENSION 3 GRANTED |
| Monday, April 26, 2021 | SOU EXTENSION 3 FILED |
| Monday, April 26, 2021 | SOU TEAS EXTENSION RECEIVED |
| Saturday, October 31, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 29, 2020 | SOU EXTENSION 2 GRANTED |
| Thursday, October 29, 2020 | SOU EXTENSION 2 FILED |
| Thursday, October 29, 2020 | SOU TEAS EXTENSION RECEIVED |
| Friday, May 1, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, April 21, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, April 17, 2020 | SOU EXTENSION 1 GRANTED |
| Friday, April 17, 2020 | SOU EXTENSION 1 FILED |
| Friday, April 17, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, November 5, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, September 10, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 10, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 21, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sunday, August 4, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, July 29, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 29, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 23, 2019 | ASSIGNED TO LIE |
| Thursday, July 18, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 22, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 22, 2019 | NON-FINAL ACTION E-MAILED |
| Tuesday, January 22, 2019 | NON-FINAL ACTION WRITTEN |
| Tuesday, January 15, 2019 | ASSIGNED TO EXAMINER |
| Friday, October 12, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, October 6, 2018 | NEW APPLICATION ENTERED |